MPs warn NICE over cancer drug 'inequities'

Patient

MPs have attacked as “inequitable and inefficient” the decision by the National Institute for Health and Clinical Excellence to allow less cost efficient drugs to be given to people at the end of their lives.

You need to be signed in to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here